“Cardiovascular disease is the leading cause of death globally, and...
Category:
Health
Latest
Study reveals importance of controlling traditional cardiovascular risk factors to prevent Alzheimer’s disease
A new study by scientists at Madrid's Centro Nacional de...
With COVID-19 ‘here to stay’, new tools essential to continue fight: Tedros
“COVID-19 is here to stay, and the world will continue to need...
Governments need to be ‘insurers of last resort’ to protect businesses from pandemic risks: Report
Jad Ariss, Managing Director, The Geneva Association, said: “It is a tragedy that businesses, particularly SMEs, have suffered so much financial loss during the pandemic as a result of the lockdowns, which were beyond their control. The public sector had to step in with multi-trillion dollar emergency relief measures. Governments and insurers must work together on how to close the massive protection gap exposed by COVID-19, with governments as the leading players.”
Maha: Poultry farmer approaches police as hens stop laying eggs
No FIR is registered as the concerned manufacturer has agreed to pay the compensation to owners of three to four poultry farms who also faced this issue.
India reports nearly 3-lakh fresh COVID-19 cases 2,023 deaths
he total number of vaccinations in the country stands at 13,01,19,310. According to the Indian Council of Medical Research (ICMR), 27,10,53,392 samples have been tested for COVID-19 up to April 20. Of these, 16,39,357 were tested yesterday.
‘Please help!’ India’s Covid-19 tragedy spills onto social media
The collapse of the country’s decrepit public health system is evident in the gut-wrenching photos on social media of multiple Covid patients sharing a single hospital bed, a line of ambulances outside a hospital in Mumbai, and people dying as they wait for oxygen. Government helplines are broken. Thousands of social media forwards plead for the antiviral drug Remdesivir, and many more seek donor plasma.
Notified new policy on rare diseases, approved budget of Rs 25 crore for treatment: Centre to HC
Regarding funding of the treatment to be provided to the children suffering from rare diseases, the ministry said that funds allocated for the purpose in the financial year 2020-21 were unutilised and lapsed.
However, Rs 4.10 crore under the rare disease component of the umbrella scheme of Rashtriya Arogya Nidhi (RAN) for 2020-21 has been remitted to AIIMS, the ministry said and added that the budget estimate for 2021-22 for treating rare diseases was Rs 25 crore and this amount can be enhanced based on its utilisation.
South Africa’s to set up vaccine compensation fund, could cost $17.5 mln in first year
“A contingent liability of approximately R250 million for the first year would be provided for compensation of vaccine injury in a COVID-19 Vaccine NFC (no-fault compensation) Fund,” Health Minister Zweli Mkhize said in written replies to a lawmaker.
Many Indians struggle to get coronavirus tests as cases rocket
Doctors and patients in New Delhi and financial hub Mumbai said it was taking between three and eight days to find slots for the highly accurate RT-PCR tests and get their results.
Covid vaccine-makers largely protected on side effects
While some governments will pay compensation due to sufferers, others assume it is the responsibility of the companies even after drug agencies back the vaccines.
In the US, the Public Readiness and Emergency Preparedness Act authorises the health secretary “to limit legal liability for losses relating to the administration of medical countermeasures such as diagnostics, treatments, and vaccines”.
Britain launches expert group to prepare for future pandemics
Launched under Britain’s Presidency of the Group of Seven (G7) rich nations, the Pandemic Preparedness Partnership (PPP) will report to the G7 leaders summit in June, and will advise on how to achieve Prime Minister Boris Johnson’s target of developing vaccines against future diseases within 100 days.
Israel logs Indian Covid-19 variant, sees some vaccine efficacy against it
An initial seven cases of the Indian variant were detected in Israel last week among people arriving from abroad and who have since undergone preliminary testing, the Health Ministry said.
“The impression is that the Pfizer vaccine has efficacy against it, albeit a reduced efficacy,” the ministry’s director-general, Hezi Levy, told Kan public radio, saying the number of cases of the variant in Israel now stood at eight.